Charlie Sheen, the well-known actor who publicly disclosed his HIV status in 2015, has revealed during a podcast appearance that he used an experimental HIV treatment called PRO 140, which he describes as more effective and with fewer side effects than existing options. Sheen stated that PRO 140, a monoclonal antibody therapy, showed quicker and more stable results, but it was never brought to market. He suggested that the drug was suppressed because it posed a threat to the pharmaceutical industry, implying that it was sidelined due to its superior efficacy. Sheen recounted that the company behind PRO 140 encountered undisclosed difficulties, preventing its release, and emphasized that the drug’s effectiveness could have revolutionized HIV treatment. His comments add to ongoing discussions about pharmaceutical industry practices and access to innovative therapies. Sheen also shared personal insights about his HIV management, linking his infection to past substance abuse, and expressed relief in having access to advanced medical treatments. He remains sober since 2017 and advocates for greater transparency and investigation into the reasons behind the drug’s suppression.